RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Pitt-Hopkins Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Pitt-Hopkins syndrome related transcription factor TCF4 binds to AmeloD and regulates ameloblast differentiation
Airi Ishikawa et al., Pediatric Dental Journal (5 October 2026)
https://doi.org/10.1016/j.pdj.2026.100398
- 2.
Interventions targeting challenges experienced by individuals with Pitt Hopkins syndrome: a scoping review.
Dolik-Michno Monika et al., Orphanet journal of rare diseases (27 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42661216/
- 3.
Characterization of Astrocyte Density in the Pitt–Hopkins Syndrome Mouse Model of Autism Spectrum Disorder
Sara M. Stump et al., Neuroglia (23 July 2026)
https://doi.org/10.3390/neuroglia7030024
- 4.
Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms in Children with Pitt-Hopkins Syndrome: A Randomized Clinical Trial
Khemlal Nirmalkar et al., Research Square (15 July 2026)
https://doi.org/10.21203/rs.3.rs-9930475/v1
- 5.
Increasing MeCP2 protein in Pitt-Hopkins syndrome model (Tcf4
Vermudez Sheryl Anne D et al., Molecular and cellular neurosciences (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41997465/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Pitt-Hopkins Syndrome
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Tooth development begins with the invagination of the epithelium and culminates in the formation of the mature tooth, a process regulated by various transcription factors. Pitt-Hopkins syndrome is a disorder characterized by craniofacial abnormalities; heterozygous mutations in the TCF4 gene are associated with distinctive facial features and severe psychomotor developmental delay. However, the role of TCF4 in tooth formation remains unclear. Using yeast two-hybrid and co-immunoprecipitation assays, we demonstrated that AmeloD, a tooth-specific transcription factor, binds directly to TCF4. Immunostaining and single-cell RNA sequencing analyses revealed that TCF4 is expressed in both dental epithelium and dental mesenchymal cells. Overexpression of AmeloD in the dental epithelial cell line SF2 induced TCF4 expression, whereas TCF4 overexpression did not induce AmeloD expression. Although stimulation with the nerve growth factor NT-4 normally induces the expression of differentiation markers such as Ambn and Enam in SF2 cells, we found that TCF4 overexpression inhibited this NT-4-induced cellular differentiation. Furthermore, this inhibitory effect was abolished by the overexpression of AmeloD. These findings reveal a novel function of TCF4, it directly inhibits AmeloD function through physical interaction. This insight is significant for elucidating the causes of the dental phenotypes observed in Pitt-Hopkins syndrome.
Common Questions
What is Pitt-Hopkins Syndrome?
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
How many clinical trials are available for Pitt-Hopkins Syndrome?
No clinical trials are currently indexed for Pitt-Hopkins Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Pitt-Hopkins Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Pitt-Hopkins Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.